![When Might a PTAB Rehearing Be Granted](/-/media/images/publications/2024/02/when-might-a-ptab-rehearing-be-granted/articleimage/when-might-a-ptab-rehearing-be-granted.jpeg?rev=42609fe150c84483ab63240429664b2f&la=en&h=675&w=1080&hash=185E1FE90895FCD02A8141BD15B0FE43)
When Might a PTAB Rehearing Be Granted?, PTAB Litigation Blog
Visit the PTAB Litigation Blog
Recently, the Patent Trial and Appeals Board (“PTAB”) granted a request for rehearing of a decision that denied an institution of inter partes review and then instituted a trial on all the challenged claims on all the grounds raised by the Petitioner regarding a patent for a cladribine regimen for treating multiple sclerosis. TWi Pharmaceuticals, Inc. v. Merck Serono SA, IPR2023-00049, Paper 15 (December 20, 2023).